article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

To add to these documents, a template for “Substantial modification of performance study under Regulation (EU) 2017/746” is also provided. It includes aspects such as home health visits, remote monitoring and diagnostics, direct-to-patient shipment of study drugs, and electronic informed consent.

article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

Plaintiff knew about it, too, since he signed an informed consent document mentioning it. Hrymoc was tried in late 2017. Equally bad, Hrymoc effectively read a New Jersey statute, §2A:58C-5(c), which precludes punitive damages where a “device” was “licensed” by the FDA, out of existence. And lost again on appeal in Cates.

FDA 105
article thumbnail

Unimpressed Learned Intermediaries Defeat Warning Causation

Drug & Device Law

The law presumes that licensed doctors know what they are doing. W]e believe that a drug manufacturer cannot be required legally to foresee that a licensed physician will disregard express warnings regarding a drug’s use. . . . Abbott Laboratories , 2017 WL 5903362, at *10 (S.D.

Doctors 59